BACILLUS CALMETTE-GUERIN

CHEBI:CHEBI_752201

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
1653484
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
dosage_form
POWDER, FOR SUSPENSION
marketing_category
BLA
pharm_class_pe
Increased Immunologically Active Molecule Activity [PE]
pharm_class
BCG Vaccine [CS]
labeler_name
Merck Sharp & Dohme LLC
manufacturer_name
Merck Sharp & Dohme LLC
active_ingredient_strength
50 mg/50mL
route
INTRAVESICAL
nui
N0000009357
generic_name
BACILLUS CALMETTE-GUERIN
brand_name
TICE BCG
brand_name_base
TICE BCG
product_ndc
0052-0602
application_number
BLA102821
marketing_start_date
19900824
package_marketing_start_date
19900824
spl_id
2070a665-d555-4886-b8f3-53b0a2213c29
active_ingredient_name
BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN
package_ndc
0052-0602-02
package_description
1 VIAL in 1 CARTON (0052-0602-02) / 50 mL in 1 VIAL (0052-0602-01)
unii
2XQ558L16Z
spl_set_id
c9b74876-e665-442b-87ad-b7333bc9a67a
upc
0300520602020
pharm_class_epc
Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]
pharm_class_cs
BCG Vaccine [CS]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class